Compare RCUS & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | XRAY |
|---|---|---|
| Founded | 2015 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2018 | 1987 |
| Metric | RCUS | XRAY |
|---|---|---|
| Price | $25.41 | $11.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $28.88 | $16.36 |
| AVG Volume (30 Days) | 1.7M | ★ 3.6M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 5.70% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $240,000,000.00 | ★ $3,624,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $9.85 |
| 52 Week High | $26.40 | $20.60 |
| Indicator | RCUS | XRAY |
|---|---|---|
| Relative Strength Index (RSI) | 71.57 | 45.59 |
| Support Level | $24.32 | $11.03 |
| Resistance Level | $26.40 | $11.44 |
| Average True Range (ATR) | 1.30 | 0.32 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 82.78 | 78.15 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).